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BACKGROUND/PURPOSE: Nosocomial bacterial resistance has been advanced and well studied in 
Taiwan, but there were few reports describing the antibiotic susceptibility of community-acquired patho-
gens. Through collecting data from those who received blood cultures in emergency department, we pre-
sented an epidemiological study to analyze appropriate empirical therapy for the community-acquired 
bacteremia in Southern Taiwan.
METHODS: From July 1998 to June 1999, patients presented at emergency department of Kaohsiung 
Veterans General Hospital with fever, chills or symptoms of sepsis were routinely performed two sets of 
blood cultures. Those of positive blood cultures without prior admission history to the hospital within 
2 weeks were further analyzed for the etiologic pathogens, antibiotic susceptibility, and risk factors of 
community-acquired bacteremia. 
RESULTS: A total of 303 episodes were enrolled for analysis, Escherichia coli, Klebsiella pneumoniae, and 
Staphylococcus aureus accounted for 76.3% of the isolates. Most of the community-acquired bacteremia was sec-
ondary bacteremia. Eighty-four percents of E. coli, 89% of K. pneumoniae, and 76% of S. aureus were susceptible to 
cefazolin. Susceptible rates of the three major pathogens to gentamicin were 72%, 92%, and 68% respectively.
CONCLUSION: While treating community-acquired bacteremia in Southern Taiwan, the first generation 
antibiotic, cefazolin plus gentamicin, was effective in vitro for the majority of cases. However, since the 
community-acquired bacteremia is mostly secondary in origin, it is necessary to explore the underlying primary 
lesions to attain therapeutic success. Further on-going epidemiological surveillance on bacterial resistance of 
community-acquired bacteremia is necessary to provide evidence-based appropriateness of empirical therapy. 
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susceptible to cefazolin and 72% to gentamicin. For 
K. pneumoniae, 89% of cases were susceptible to cefazolin 
and 92% to gentamicin. For S. aureus, 76% of cases were sus-
ceptible to cefazolin and 76% to oxacillin (Tables 2 and 3). 
For Gram-negative isolates, the susceptibility rates to 
cefuroxime, amoxicillin/clavulanate, amikacin, aztreonam, 
ceftazidime, ciprofloxacin, and imipenem/cilastatin were 
over 80% for both E. coli and K. pneumoniae. Piperacillin 
was active against 31% of E. coli and 58% of K. pneumoniae 
infections. For Gram-positive strains, susceptibility rates 
to clindamycin were 68% for S. aureus and 100% for 
Streptococcus spp. Ciprofloxacin was active against 72% of 
S. aureus, 100% of Streptococcus spp., and 80% of Enterococcus 
spp. Vancomycin was active against 100% of S. aureus, 
Streptococcus spp., and Enterococcus spp.
Discussion
In our study, most of the community-acquired infections 
were secondary to an underlying focus in patients with 
certain predisposing factors, or underlying diseases. 
Urinary tract infections related to urolithiasis, benign 
prostatic hypertrophy, and urinary catheterization were 
caused by E. coli infection, which was the leading cause of 
bacteremia. Liver cirrhosis, biliary tract stones, and diabetes 
Introduction
Antibiotic-resistant organisms causing nosocomial 
infection have emerged worldwide in recent decades, 
including Taiwan.1–6 However, data regarding the antibiotic 
susceptibility of community-acquired pathogens is lacking, 
and empirical antibiotic therapy for sepsis is still controver-
sial in Taiwan. Therefore, we conducted a prospective study 
of the period from July 1998 to June 1999 to investigate 
the epidemiological data on the bacterial resistance of 
causing community-acquired bacteremia in patients 
treated at the Veterans General Hospital in Kaohsiung, a 
tertiary medical center with 1,100 beds located in 
Southern Taiwan. The emergency department in this hos-
pital receives around 140–180 cases per day, including 
patients with fever and sepsis.
Materials and Methods
Two sets of blood cultures were routinely performed 
on patients presenting with fever, chills, and/or signs of 
sepsis, and those with positive blood culture results were 
included in the study. Those patients with only one set of 
blood cultures positive for coagulase-negative staphyloco-
ccus were excluded. Patients that had been admitted to 
any hospital within the 2 weeks prior to presenting at the 
emergency department of the Veterans General Hospital 
in Kaohsiung were also excluded.
The antimicrobial susceptibility of the clinical isolates 
was determined by minimal inhibitory concentration using 
the MicroScan system. The antibiotics tested included 
ampicillin, amoxicillin/clavulanate, cefazolin, cephalothin, 
cefuroxime, ceftazidime, piperacillin, ciprofloxacin, imi-
penem, amikacin, gentamicin, sulfamethoxazole/trimeth-
oprim, tetracycline, chloramphenicol, vancomycin, and 
rifampicin. 
Results
After excluding seven cases due to contamination, a total 
of 303 cases of community-acquired bacteremia were 
enrolled. Escherichia coli (n = 140, 46.2%), Klebsiella pneumoniae 
(n = 66, 21.8%), and Staphylococcus aureus (n = 25, 8.3%) con-
stituted the three major pathogens, and accounted for 
76.3% of the isolates (Table 1). For E. coli, 84% of cases were 
Table 1. Distribution of pathogens causing community-
acquired bacteremia (n = 303)
Isolates n (%)
Escherichia coli 140 (46.2)
Klebsiella pneumoniae 66 (21.8)
Staphylococcus aureus 25 (8.3)
Streptococcus spp. 12 (4.0)
Pseudomonas aeruginosa 11 (3.6)
Enterococcus spp. 9 (3.0)
Proteus mirabilis 8 (2.6)
Aeromonas hydrophila 8 (2.6)
Acinetobacter baumannii 6 (2.0)
Morganella morganii 5 (1.7)
Salmonella spp. 4 (1.3)
Enterobacter cloacae 4 (1.3)
Pasteurella multocida 2 (0.7)
Acinetobacter spp. 1 (0.3)
Moraxella osloensis 1 (0.3)
Pseudomonas alcaligenes 1 (0.3)
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mellitus were the major predisposing factors for abdomi-
nal and biliary sepsis, which was the second most com-
mon cause of bacteremia. Diabetic patients with primary 
K. pneumoniae-infected liver abscesses and secondary bac-
teremia are very unique in Taiwan.7,8 Therefore, explora-
tion of the underlying primary lesions using imaging 
studies such as ultrasonography is required.
The definition of community-acquired bacteremia in 
the literature varies, which may have an influence on 
which strains are included in the various studies.2 As some 
of the strains that we isolated were from patients with a 
history of admission to an intensive care unit more than 2 
weeks prior to visiting the emergency department, they 
may have been the reason for the isolation of multi-drug 
resistant strains such as Pseudomonas aeruginosa, Acineto-
bacter baumannii, and Enterobacter cloacae. This suggests a 
need to revise the inclusion criteria, because these patients 
might have been colonized by nosocomial strains even 
though they had been discharged from hospitals, or 
chronic care facilities, for more than 14 days.9
Based on the epidemiological data available for 
Southern Taiwan, the three major pathogens appear to be 
Table 2. The susceptibility rates of community-acquired Gram-negative bacteremia strains to antibiotics (Veterans General 
Hospital in Kaohsiung, 1999)
Antibiotics Susceptibility rate
Gram- CZ CF GM AMP SMX/ C CXM AMC AN AZT CAZ IMP PIP CIPnegative strains     TMP
Escherichia coli 84 20 72 26 43 53 86 82 96 96 96 96 31 95
Klebsiella pneumoniae 89 88 92 12 77 82 95 91 98 97 95 98 58 95
Pseudomonas aeruginosa 0 0 64 0 9 0 0 9 91 82 73 100 73 91
Proteus mirabilis 63 63 50 38 25 38 100 75 75 63 75 100 38 63
Aeromonas spp. 37.5 37.5 87.5 12.5 88 88 62.5 25 100 50 75 100 50 100
Acinetobacter baumannii 0 0 50 − 33 0 0 67 67 0 67 83 33 67
Morganella morganii 0 0 0 0 0 0 0 0 80 100 100 100 0 60
Salmonella spp. − − − 50 75 25 − 75 − − 75 75 − 75
Enterobacter cloacae 0 0 75 0 75 75 50 0 100 75 75 100 75 100
Pasteurella multocida 100 100 100 0 100 0 100 100 − − − 100 0 100
Acinetobacter spp. 0 0 100 − 100 100 100 100 − − − 100 100 100
Moraxella osloensis 100 100 100 − 100 100 100 100 − − − 100 100 100
Pseudomonas alcaligenes 0 0 100 − 0 0 0 100 − − − 100 100 100
CZ = cefazolin; CF = cephalothin; GM = gentamicin; AMP = ampicillin; SMX/TMP = sulfamethoxazole/trimethoprim; C = chloramphenicol; 
CXM = cefuroxime; AMC = amoxicillin/clavulanate; AN = amikacin; AZT = aztreonam; CAZ = ceftazidime; IMP = imipenem; PIP = piperacillin; 
CIP = ciprofloxacin.
Table 3. The susceptibility rates of community-acquired Gram-positive bacteremia strains to antibiotics (Veterans General 
Hospital in Kaohsiung, 1999)
Antibiotics Susceptibility rate
Gram- 
PCN AMP CZ TC OXA E SMX/TMP CC  RIF CIP IMP VANpositive strains
Staphylococcus aureus  4 4 76 60 76 60 80 68 92 72 76 100
Streptococcus spp.a  100 100 100 − 100 100 100 100 100 100 100 100
Enterococcus spp. 40 40 − − − 20 − − 20 80 40 100
aincluding Strep. bovis, Strep. Gr A, B, and G. PCN = penicillin; AMP = ampicillin; CZ = cefazolin; TC = tetracycline; OXA = oxacillin; E = erythromycin; 
SMX/TMP = sulfamethoxazole/trimethoprim; CC = clindamycin; RIF = rifampicin; CIP = ciprofloxacin; IMP = imipenem; VAN = Vancomycin. 
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E. coli, K. pneumoniae, and S. aureus. This strongly suggests 
that therapy for patients with community-acquired bac-
teremia should focus on these three pathogens, and a 
combination of cefazolin and gentamicin seems to be an 
appropriate treatment, although oxacillin could be used 
to treat Gram-positive bacteremia. For patients with more 
critical conditions, such as severe sepsis, it might be cost-
effective to use cefuroxime or amoxicillin/clavulanate for 
probable Gram-negative bacteremia, and vancomycin for 
suspected Gram-positive bacteremia. Piperacillin was not 
an adequate treatment for community-acquired bactere-
mia due to its low susceptibility rate. Though aztreonam, 
ceftazidime, imipenem/cilastatin, and ciprofloxacin showed 
good activity in vitro, they are expensive and should be 
reserved for nosocomial infections.
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